alpha,alpha-trehalose

Term ID

CHEBI:16551

Synonyms

(Glc)2
alpha,alpha'-Trehalose
alpha,alpha-trehalose
alpha-D-Glcp-(1<->1)-alpha-D-Glcp
alpha-D-glucopyranosyl alpha-D-glucopyranoside
alpha-D-glucopyranosyl-alpha-D-glucopyranoside
alpha-D-Trehalose
alpha-trehalose
D-(+)-trehalose
ergot sugar
mycose
TREHALOSE

Definition

A trehalose in which both glucose residues have alpha-configuration at the anomeric carbon.

References

CAS:99-20-7
Gmelin:2145829
HMDB:HMDB0000975
KEGG:C01083
KEGG:G00293
KNApSAcK:C00001152
LINCS:LSM-37121
MetaCyc:TREHALOSE
PDBeChem:TRE
PMID:17439666
PMID:20477758
Reaxys:1292766
Wikipedia:Trehalose

Ontology

ChEBI ( EBI )

Resources

CTD

Relationships

is a type of: trehalose

trehalose Show first 5 Terms
has_role: Escherichia coli metabolite geroprotector human metabolite mouse metabolite Saccharomyces cerevisiae metabolite

Escherichia coli metabolite geroprotector human metabolite mouse metabolite Saccharomyces cerevisiae metabolite Show first 5 Terms
inverse has_functional_parent: 2'-O-sulfo-2-O-tetracosanoyl-3-O-[(2E,4S,6S,8S)-2,4,6,8-tetramethyltetracos-2-enoyl]-alpha,alpha-trehalose 2,3-dipalmitoyl-2'-sulfo-alpha,alpha-trehalose 2-O-(long-chain fatty acyl)-3-O-mycolipenoyl-trehalose 2-O-[(2E,4S)-2,4-dimethyldocos-2-enoyl]-3-O-palmitoyl-2'-O-sulfo-alpha,alpha-trehalose 2-O-octanoyl-2'-O-sulfo-3-O-[(2E,4S,6S,8S)-2,4,6,8-tetramethyltetracos-2-enoyl]-alpha,alpha-trehalose ... Show All 35 Terms

2'-O-sulfo-2-O-tetracosanoyl-3-O-[(2E,4S,6S,8S)-2,4,6,8-tetramethyltetracos-2-enoyl]-alpha,alpha-trehalose 2,3-dipalmitoyl-2'-sulfo-alpha,alpha-trehalose 2-O-(long-chain fatty acyl)-3-O-mycolipenoyl-trehalose 2-O-[(2E,4S)-2,4-dimethyldocos-2-enoyl]-3-O-palmitoyl-2'-O-sulfo-alpha,alpha-trehalose 2-O-octanoyl-2'-O-sulfo-3-O-[(2E,4S,6S,8S)-2,4,6,8-tetramethyltetracos-2-enoyl]-alpha,alpha-trehalose 2-O-palmitoyl-2'-O-sulfo-3-O-[(2E,4S,6S,8S)-2,4,6,8-tetramethylhexadec-2-enoyl]-alpha,alpha-trehalose 2-O-palmitoyl-2'-O-sulfo-3-O-[(2E,4S,6S,8S)-2,4,6,8-tetramethyltetracos-2-enoyl]-alpha,alpha-trehalose 2-O-palmitoyl-2'-O-sulfo-3-O-[(2E,4S,6S,8S)-2,4,6,8-tetramethyltriacont-2-enoyl]-alpha,alpha-trehalose 2-O-palmitoyl-2'-O-sulfo-3-O-[(2S,4S,6S)-2,4,6-trimethyltetracosanoyl]-alpha,alpha-trehalose 2-O-palmitoyl-2'-O-sulfo-3-O-[(2S,4S,6S,8S)-2,4,6,8-tetramethyltetracosanoyl]-alpha,alpha-trehalose 2-O-palmitoyl-2'-O-sulfo-3-O-triacontanoyl-alpha,alpha-trehalose 2-O-palmitoyl-3-O-[(2E,4S,6S)-2,4,6-trimethyltetracos-2-enoyl]-2'-O-sulfo-alpha,alpha-trehalose 2-O-palmitoyl-3-O-[(2E,4S,6S,8S,10S)-2,4,6,8,10-pentamethylhexacos-2-enoyl]-2'-O-sulfo-alpha,alpha-trehalose 2-O-sulfo-2'-O-stearoyl-alpha,alpha-trehalose(1-) 3-O-(2-methyloctadecanoyl)-2-O-palmitoyl-2'-O-sulfo-alpha,alpha-trehalose 3-O-(16-hydroxyhexadecanoyl)-2-O-palmitoyl-2'-O-sulfo-alpha,alpha-trehalose 3-O-[(2E)-2-methylicos-2-enoyl]-2-O-palmitoyl-2'-O-sulfo-alpha,alpha-trehalose 3-O-[(2E,4R)-2,4-dimethyldocos-2-enoyl]-2-O-palmitoyl-2'-O-sulfo-alpha,alpha-trehalose 3-O-[(2E,4S)-2,4-dimethyldocos-2-enoyl]-2-O-palmitoyl-2'-O-sulfo-alpha,alpha-trehalose 3-O-[(2S,4S)-2,4-dimethyldocosanoyl]-2-O-palmitoyl-2'-O-sulfo-alpha,alpha-trehalose 3-O-hydroxyphthioceranoyl-2-O-palmitoyl-2'-O-sulfo-alpha,alpha-trehalose 3-O-hydroxyphthioceranoyl-2-O-stearoyl-2'-O-sulfo-alpha,alpha-trehalose acyl alpha,alpha-trehalose alpha,alpha-trehalose 6-phosphate alpha,alpha-trehalose 6-phosphate(2-) alpha,alpha-trehalose-2-sulfate alpha,alpha-trehalose-2-sulfate(1-) beta-D-Galp-(1->6)-alpha-D-Glcp-(1->1)-alpha-D-Glcp brartemicin monoacyl alpha,alpha-trehalose polyacyl alpha,alpha-trehalose SL659 SL1278 sulfolipid I sulfolipid-1(1-) Show first 5 Terms

Phenotype

Phenotype resulting from alpha,alpha-trehalose

Phenotype where environments contain alpha,alpha-trehalose

Phenotype modified by environments containing alpha,alpha-trehalose

Human Disease Model